Suraksha Diagnostic Quarterly Results for Trading Insights
In Sept 2025, Suraksha Diagnostic (SURAKSHA) reported revenue ₹80 Cr and net profit ₹9 Cr — revenue +17.6% YoY. For annual financials, live price and key ratios, visit SURAKSHA stock overview.
SURAKSHA Quarterly Results — Revenue, Profit & EPS Highlights
Suraksha Diagnostic latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with SURAKSHA stock valuation models to assess whether the stock is under or overvalued.
- Revenue of ₹80 Cr in Sept 2025 (+21.2% vs Mar 2025, +17.6% vs Sept 2024)
- Net Profit of ₹9 Cr in Sept 2025 (+28.6% vs Mar 2025, -10.0% vs Sept 2024)
- EBITDA of ₹25 Cr in Sept 2025 (+25.0% vs Mar 2025)
- Operating Margin of 31.0% in Sept 2025 (+2.0pp vs Mar 2025)
- Earnings Per Share of ₹1.73 in Sept 2025 (+21.8% vs Mar 2025)
Suraksha Diagnostic Quarterly Results — Revenue, EBITDA, Net Profit & EPS
SURAKSHA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 80 | 66 | 74 | 78 | 68 | 21.2% | 17.6% |
| Net Profit (₹ Cr) | 9 | 7 | 9 | 7 | 10 | - | - |
| EBITDA (₹ Cr) | 25 | 20 | 25 | 24 | 25 | - | - |
| EPS (₹) | 1.73 | 1.42 | 1.80 | 1.44 | 1.94 | - | - |
| Operating Margin (%) | 31.0% | 29.0% | 33.0% | 30.0% | 35.0% | - | - |
SURAKSHA Share Price Trend — 1-Year Movement Across Quarterly Results
Suraksha Diagnostic 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse SURAKSHA shareholder distribution to track promoter, FII and institutional holdings.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
SURAKSHA vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Suraksha Diagnostic latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Sept 2025 |
₹111,181.49 Cr | 7709.0 | 6,365 | 494 | +12.4% | - | 7.8% | 232.3 |
|
Max Healthcare Inst…
Sept 2025 |
₹97,775.70 Cr | 1006.6 | 2,168 | 491 | +10.8% | - | 22.6% | 199.3 |
|
Fortis Healthcare
Sept 2025 |
₹71,815.39 Cr | 935.2 | 2,381 | 329 | +17.2% | - | 13.8% | 219.5 |
|
Aster DM Healthcare
Sept 2025 |
₹36,543.08 Cr | 699.5 | 1,226 | 121 | +18.8% | - | 9.9% | 328.4 |
|
Narayana Hrudayalaya
Sept 2025 |
₹35,906.19 Cr | 1770.4 | 1,668 | 259 | +11.0% | - | 15.5% | 139.2 |
All amounts in ₹ Crores